Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-21

Clinical Trial Update: Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology

View source ↗

Summary

This update describes the evaluation of Zetiq Technologies' Cell Detect method for detecting bladder cancer in urine cytology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zetiq Technologies | Conditions: Bladder Cancer Transitional Cell Carcinoma | Status: UNKNOWN